Alejandro González Veliz: SCO May Be One of the Most Misunderstood Areas in Interventional Cardiology
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about recent article by Michaella Alexandrou et al., published in European Heart Journal, adding:
“Subacute coronary occlusion (SCO) may be one of the most misunderstood areas in interventional cardiology.
These patients exist in the space between acute STEMI and chronic total occlusion:not unstable enough for automatic emergent PCI…but not truly ‘stable’ either.
The challenge?
The myocardium may still be viable.
Ischemia may still be ongoing.
But procedural risks also increase significantly.
This is where physiology becomes more important than the clock.
Modern decision-making increasingly depends on:
- Myocardial viability
- Ongoing ischemia
- Residual coronary flow
- Hemodynamic stability
- Individualized risk-benefit assessment
The classic binary model:
‘open immediately’ vs ‘treat medically’ is no longer enough.
Subacute coronary occlusions represent the true grey zone of coronary intervention.”

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026